Skip to main content
. Author manuscript; available in PMC: 2020 Apr 1.
Published in final edited form as: J Clin Epidemiol. 2018 Dec 7;108:34–43. doi: 10.1016/j.jclinepi.2018.11.024

Figure 1.

Figure 1.

Proportion of total disease burden and economic costs associated with exposure to endocrine-disrupting chemicals in the US according to race/ethnicity (base case estimates)